Objective: To verify the efficacy and safety of dual antiplatelet therapy after intravenous
thrombolysis for acute minor ischemic stroke (AMIS). Methods: AMIS patients who received …

Background and purpose: The optimal treatment for acute ischemic stroke with mild
neurologic deficits is unclear. We aimed to compare the efficacy and safety of alteplase …

Objective Intravenous thrombolysis (IVT) has been shown to effectively decrease both the
disability rate and mortality associated with acute ischemic stroke, however, there is also a …

Background A recent study shows that dual antiplatelet therapy with clopidogrel plus aspirin
is superior to aspirin monotherapy for minor stroke, which is defined as a National Institutes …

Importance Intravenous thrombolysis is increasingly used in patients with minor stroke, but
its benefit in patients with minor nondisabling stroke is unknown. Objective To investigate …

Objective: To evaluate the efficacy and safety of short-term high-dose of dual antiplatelet
therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke (AIS) …

Objective: The objective of this study was to investigate the long-term effect of dual
antiplatelet therapy (DAPT) using clopidogrel plus aspirin versus aspirin monotherapy after …

Abstract Background and Purpose Sex is associated with clinical outcome in stroke. The
present study aimed to determine the effect of sex on efficacy of dual antiplatelet (DAPT) …

Stroke was one of the most frequent diseases with significant disability and mortality.[1]
Several studies confirmed that intravenous thrombolysis with alteplase can effectively …

Background: Minor stroke, defined as a National Institutes of Health Stroke Scale (NIHSS),
score of less than or equal to 5, accountedfor half of Acute Ischemic Stroke (AIS) patients in …